 low-dos zidovudin children human immunodefici viru type infect perinat period report one-year result noncompar studi safeti toler low-dos zidovudin azidothymidin human immunodefici viru type infant children baselin mean age year symptomat diseas control classif patient zidovudin month full year therapi mean durat follow-up day rang day initi therapi daili dose day equival mg/kg day treatment neutropenia anemia twenty-nin children initi therapi entir studi zidovudin dosag time children due time full-dos therapi total durat protocol patient children mild symptom studi entri like full-dos therapi children sever symptom time full-dos therapi durat protocol former group latter clinic advers experi thirty-seven children trimethoprim-sulfametoxazol prophylaxi pneumocysti carinii pneumonia